
Christopher Upton
Examiner (ID: 3762, Phone: (571)272-1169 , Office: P/1778 )
| Most Active Art Unit | 1778 |
| Art Unit(s) | 1797, 1306, 1308, 1776, 1778, 1724 |
| Total Applications | 3146 |
| Issued Applications | 2580 |
| Pending Applications | 123 |
| Abandoned Applications | 451 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7202248
[patent_doc_number] => 20040086903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-06
[patent_title] => 'Epididymal lipocalin gene and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/451867
[patent_app_country] => US
[patent_app_date] => 2003-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 25134
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20040086903.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451867 | Epididymal lipocalin gene and uses thereof | Oct 27, 2003 | Abandoned |
Array
(
[id] => 7161178
[patent_doc_number] => 20050084869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-04-21
[patent_title] => 'Novel composition and methods for the diagnosis of lung cancer'
[patent_app_type] => utility
[patent_app_number] => 10/689862
[patent_app_country] => US
[patent_app_date] => 2003-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 10232
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20050084869.pdf
[firstpage_image] =>[orig_patent_app_number] => 10689862
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/689862 | Novel composition and methods for the diagnosis of lung cancer | Oct 19, 2003 | Abandoned |
Array
(
[id] => 7236240
[patent_doc_number] => 20040073959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Genetic control of sex ratio in animal populations'
[patent_app_type] => new
[patent_app_number] => 10/398482
[patent_app_country] => US
[patent_app_date] => 2003-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19288
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20040073959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398482
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398482 | Genetic control of sex ratio in animal populations | Oct 13, 2003 | Abandoned |
Array
(
[id] => 7275706
[patent_doc_number] => 20040235157
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein'
[patent_app_type] => new
[patent_app_number] => 10/677777
[patent_app_country] => US
[patent_app_date] => 2003-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 17287
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235157.pdf
[firstpage_image] =>[orig_patent_app_number] => 10677777
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/677777 | Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein | Oct 2, 2003 | Issued |
Array
(
[id] => 7324048
[patent_doc_number] => 20040137626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-15
[patent_title] => 'AAV ITR-mediated modulation'
[patent_app_type] => new
[patent_app_number] => 10/669641
[patent_app_country] => US
[patent_app_date] => 2003-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4526
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20040137626.pdf
[firstpage_image] =>[orig_patent_app_number] => 10669641
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/669641 | AAV ITR-mediated modulation | Sep 24, 2003 | Abandoned |
Array
(
[id] => 7199975
[patent_doc_number] => 20050042204
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-24
[patent_title] => 'Method to protect transgenes from silencing'
[patent_app_type] => utility
[patent_app_number] => 10/667359
[patent_app_country] => US
[patent_app_date] => 2003-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3939
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20050042204.pdf
[firstpage_image] =>[orig_patent_app_number] => 10667359
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/667359 | Method to protect transgenes from silencing | Sep 22, 2003 | Abandoned |
Array
(
[id] => 5843076
[patent_doc_number] => 20060121477
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-08
[patent_title] => 'Method for detection of micro-metastasis'
[patent_app_type] => utility
[patent_app_number] => 10/527824
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4793
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20060121477.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527824
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527824 | Method for detection of micro-metastasis | Sep 11, 2003 | Abandoned |
Array
(
[id] => 7286919
[patent_doc_number] => 20040146935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Disease associated gene'
[patent_app_type] => new
[patent_app_number] => 10/471567
[patent_app_country] => US
[patent_app_date] => 2003-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8499
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20040146935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10471567
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/471567 | Disease associated gene | Sep 10, 2003 | Abandoned |
Array
(
[id] => 7236229
[patent_doc_number] => 20040073958
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Transgenic animal having drug metabolism enzyme gene and utilization thereof'
[patent_app_type] => new
[patent_app_number] => 10/296242
[patent_app_country] => US
[patent_app_date] => 2003-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12095
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20040073958.pdf
[firstpage_image] =>[orig_patent_app_number] => 10296242
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/296242 | Transgenic animal having drug metabolism enzyme gene and utilization thereof | Sep 10, 2003 | Abandoned |
Array
(
[id] => 7243304
[patent_doc_number] => 20050271637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'BMP-2 estrogen responsive element and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 10/642503
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11562
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0271/20050271637.pdf
[firstpage_image] =>[orig_patent_app_number] => 10642503
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/642503 | BMP-2 estrogen responsive element and methods of using the same | Aug 17, 2003 | Abandoned |
Array
(
[id] => 7139053
[patent_doc_number] => 20040045041
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Means for the identification compounds capable of inhibiting karap-transduced signals'
[patent_app_type] => new
[patent_app_number] => 10/381018
[patent_app_country] => US
[patent_app_date] => 2003-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 15981
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20040045041.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381018
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381018 | Means for the identification compounds capable of inhibiting karap-transduced signals | Aug 17, 2003 | Abandoned |
Array
(
[id] => 7313067
[patent_doc_number] => 20040143863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Hematopoietic stem cell niche cells'
[patent_app_type] => new
[patent_app_number] => 10/641319
[patent_app_country] => US
[patent_app_date] => 2003-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15452
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20040143863.pdf
[firstpage_image] =>[orig_patent_app_number] => 10641319
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/641319 | Hematopoietic stem cell niche cells | Aug 13, 2003 | Abandoned |
Array
(
[id] => 5776321
[patent_doc_number] => 20060104961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-18
[patent_title] => 'Mechanisms of myoblast transfer in treating heart failure'
[patent_app_type] => utility
[patent_app_number] => 10/523969
[patent_app_country] => US
[patent_app_date] => 2003-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3481
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20060104961.pdf
[firstpage_image] =>[orig_patent_app_number] => 10523969
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/523969 | Mechanisms of myoblast transfer in treating heart failure | Aug 5, 2003 | Abandoned |
Array
(
[id] => 5894866
[patent_doc_number] => 20060003405
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'Method of expressing recombinant protein in cho cells'
[patent_app_type] => utility
[patent_app_number] => 10/521768
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7760
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003405.pdf
[firstpage_image] =>[orig_patent_app_number] => 10521768
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/521768 | Method of expressing recombinant protein in cho cells | Jul 20, 2003 | Abandoned |
Array
(
[id] => 7393137
[patent_doc_number] => 20040038247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-26
[patent_title] => 'Nucleic acid constructs including a novel t-cell active promoters, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response'
[patent_app_type] => new
[patent_app_number] => 10/362010
[patent_app_country] => US
[patent_app_date] => 2003-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8969
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0038/20040038247.pdf
[firstpage_image] =>[orig_patent_app_number] => 10362010
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/362010 | Nucleic acid constructs including a novel t-cell active promoters, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response | Jul 20, 2003 | Abandoned |
Array
(
[id] => 658318
[patent_doc_number] => 07105496
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-12
[patent_title] => 'Methods and compositions for inhibiting angiogenesis'
[patent_app_type] => utility
[patent_app_number] => 10/603387
[patent_app_country] => US
[patent_app_date] => 2003-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 46
[patent_no_of_words] => 22509
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/105/07105496.pdf
[firstpage_image] =>[orig_patent_app_number] => 10603387
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/603387 | Methods and compositions for inhibiting angiogenesis | Jun 24, 2003 | Issued |
Array
(
[id] => 7463770
[patent_doc_number] => 20040053299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-18
[patent_title] => 'Regulated activation of cell-membrane receptors by metal-chelating agonists'
[patent_app_type] => new
[patent_app_number] => 10/451296
[patent_app_country] => US
[patent_app_date] => 2003-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5100
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20040053299.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451296
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451296 | Regulated activation of cell-membrane receptors by metal-chelating agonists | Jun 18, 2003 | Abandoned |
Array
(
[id] => 5894772
[patent_doc_number] => 20060003311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'In vitro screening of cellular events using 3d cell culture systems'
[patent_app_type] => utility
[patent_app_number] => 10/517497
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10478
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003311.pdf
[firstpage_image] =>[orig_patent_app_number] => 10517497
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/517497 | In vitro screening of cellular events using 3d cell culture systems | Jun 11, 2003 | Abandoned |
Array
(
[id] => 754129
[patent_doc_number] => 07018834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-03-28
[patent_title] => 'Mutated herpes simplex virus type 1 thymidine kinases and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 10/457604
[patent_app_country] => US
[patent_app_date] => 2003-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 21
[patent_no_of_words] => 10724
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/018/07018834.pdf
[firstpage_image] =>[orig_patent_app_number] => 10457604
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/457604 | Mutated herpes simplex virus type 1 thymidine kinases and uses thereof | Jun 8, 2003 | Issued |
Array
(
[id] => 6703279
[patent_doc_number] => 20030226159
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-12-04
[patent_title] => 'Cancer models'
[patent_app_type] => new
[patent_app_number] => 10/414460
[patent_app_country] => US
[patent_app_date] => 2003-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10800
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20030226159.pdf
[firstpage_image] =>[orig_patent_app_number] => 10414460
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/414460 | Cancer models | Apr 14, 2003 | Abandoned |